國際商業結算控股有限公 司 （於百慕達註冊成立之有限公司） （股份代號：00147） 盈利警告 本公佈乃由國際商業結算控股有限公司（「本公司」，連同其附屬公司統稱「本集團」）根據香港 聯合交易所有限公司證券上市規則（「上市規則」）第13.09(2)(a)條及香港法例第571章證券及期 貨條例第XIVA部之內幕消息條文（定義見上市規則）而作出。 本公司董事（「董事」）會（「董事會」）謹此通知本公司股東（「股東」）及潛在投資者，根據對本集 團截至二零二五年三月三十一日止年度之未經審核綜合管理賬目作出之初步審閱，並考慮到 董事會現有的資料，與截至二零二四年三月三十日止年度之經審核綜合年內虧損約125百萬港 元相比，本集團預期截至二零二五年三月三十一日止年度錄得綜合虧損約400百萬港元，同比 大幅增加約220%。有關虧損增加主要由於(i)承租人應收本集團數據存儲設備之租賃費用減值 虧損撥備；(ii)出租數據存儲設備之價值減值虧損撥備；及(iii)由於中國房地產市場情況欠佳， 故在建物業及待售物業減值虧損撥備增加。 由於本公司仍在預備本集團截至二零二五年三月三十一日止年度之全年業績。本公佈內的資 料僅根據本集團管理層對 ...

（於百慕達註冊成立之有限公司） （股份代號：00147） 董事會會議召開日期 香港交易及結算所有限公司及香港聯合交易所有限公司對本公佈之內容概不負責，對其 準確性或完整性亦不發表任何聲明，且表明不會就因本公佈全部或任何部份內容或因倚 賴該等內容而引致之任何損失承擔任何責任。 執行董事 INTERNATIONAL BUSINESS SETTLEMENT HOLDINGS LIMITED 國 際 商 業 結 算 控 股 有 限 公 司 袁亮 國際商業結算控股有限公司（「本公司」）之董事會（「董事會」）謹此宣佈，本公司 將於二零二五年六月二十七日(星期五)舉行董事會會議，藉以(其中包括)考慮及批准本公 司及其附屬公司截至二零二五年三月三十一日止年度之經審核全年業績及其發佈，以及 考慮派發末期股息(如有)。 承董事會命 國際商業結算控股有限公司 香港，二零二五年六月十七日 於本公佈日期，董事會由執行董事袁亮先生及陳少達先生；非執行董事劉雨先生及獨立 非執行董事葉勇先生、陳嵐冉女士及王建平先生組成。 ...

Group 1 - The core viewpoint of the news highlights the performance of International Business Settlement (IBS) in the Hong Kong stock market, noting a recent increase in stock price despite significant year-to-date declines [1] - As of June 9, the Hang Seng Index rose by 1.63%, while IBS's stock price increased by 14.0% to HKD 0.057 per share, with a trading volume of 915,000 shares and a turnover of HKD 49,300 [1] - IBS has experienced a cumulative decline of 10.71% over the past month and a 43.18% decline year-to-date, underperforming the Hang Seng Index by 18.61% [1] Group 2 - Financial data for IBS shows total revenue of HKD 96.37 million for the year ending September 30, 2024, representing a year-on-year growth of 6.7%, while the net profit attributable to shareholders was a loss of HKD 43.06 million, an increase of 26.4% [1] - The gross profit margin for IBS stands at 12.89%, with a debt-to-asset ratio of 75.01% [1] - Currently, there are no institutional investment ratings for IBS [1] Group 3 - IBS aims to become a leading global fintech company, leveraging distributed networks and blockchain technology to create a next-generation global clearing and settlement network [2] - The company focuses on connecting with real-time clearing systems of central banks to provide efficient, low-cost financial services for cross-border trade, particularly targeting countries along the Belt and Road Initiative [2] - IBS is building a multi-currency, international, and distributed global clearing platform, which is designed to facilitate real-time fund clearing and settlement across various regions, enhancing connectivity between sovereign nations [2]

Company Overview - International Business Settlement Holdings Limited (IBS) aims to become a leading global fintech company, leveraging distributed networks and blockchain technology to establish a next-generation global clearing and settlement network [3] - The company focuses on providing a fast, efficient, and low-cost financial highway for cross-border transactions, connecting with real-time clearing systems of various central banks [3] Financial Performance - As of September 30, 2024, IBS reported total revenue of 96.37 million HKD, a year-on-year increase of 6.7% [1] - The company recorded a net profit attributable to shareholders of -43.06 million HKD, reflecting a year-on-year growth of 26.4% [1] - The gross profit margin stood at 12.89%, with a debt-to-asset ratio of 75.01% [1] Market Position - IBS's price-to-earnings (P/E) ratio is -23.41, ranking 104th in its industry, which has an average P/E ratio of 4.81 [2] - The company has underperformed the Hang Seng Index, with a cumulative decline of 44.32% year-to-date, compared to the index's increase of 17.51% [1] Industry Context - The fintech sector is experiencing significant transformation and development opportunities globally, with IBS positioning itself to capitalize on these trends [3] - The company aims to build a multi-currency, international, and distributed global clearing platform, targeting markets along the Belt and Road Initiative [3]

Core Insights - ST Xiangxue (300147.SZ) reported a total operating revenue of 1.859 billion yuan for 2024, ranking 39th among disclosed peers, which represents a decrease of 441 million yuan or 19.16% year-on-year [1] - The company recorded a net profit attributable to shareholders of -859 million yuan, ranking 68th among peers, a decline of 470 million yuan compared to the same period last year [1] - Operating cash flow showed a net inflow of 18.17 million yuan, ranking 53rd among peers, down 245 million yuan or 93.10% year-on-year [1] Financial Ratios - The latest debt-to-asset ratio stands at 80.81%, ranking 66th among peers, an increase of 8.75 percentage points from the previous year [3] - The latest gross profit margin is 24.36%, ranking 64th among peers [3] - Return on equity (ROE) is reported at -81.39%, ranking 66th among peers, a decrease of 61.18 percentage points year-on-year [3] - The diluted earnings per share is -1.30 yuan, ranking 67th among peers, a reduction of 0.71 yuan compared to the same period last year [3] - The total asset turnover ratio is 0.24 times, ranking 60th among peers, a decline of 0.04 times or 13.29% year-on-year [3] - The inventory turnover ratio is reported at 3.74 times [3] Shareholder Structure - The number of shareholders is 63,500, with the top ten shareholders holding 196 million shares, accounting for 29.62% of the total share capital [3] - The largest shareholder is Guangzhou Kunlun Investment Co., Ltd., holding 22.5 million shares [3] - Other notable shareholders include Guangzhou Luogang Water Supply Co., Ltd. (4.06 million shares) and various institutional investors [3]

Group 1 - The stock price of ST Xiangxue (300147) closed at 4.95 yuan, down 17.77% as of April 7, 2025, with a turnover rate of 6.27% and a trading volume of 412,200 hands, amounting to 224 million yuan [1] - The latest financial results for ST Xiangxue show total operating revenue of 1.534 billion yuan, a year-on-year decrease of 11.26%, and a net profit attributable to shareholders of 217.8 million yuan, down 49.10% year-on-year [1] - The company has a current ratio of 0.360, a quick ratio of 0.279, and a debt-to-asset ratio of 73.72% [1] Group 2 - ST Xiangxue has made investments in 39 companies and participated in 2,125 bidding projects, indicating active engagement in business expansion [2] - The company holds 242 trademark registrations and 166 patents, showcasing its focus on intellectual property [2] - Additionally, ST Xiangxue possesses 239 administrative licenses, reflecting its compliance and operational capabilities [2]

Core Viewpoint - Xiangxue Pharmaceutical has been penalized for information disclosure violations, leading to a warning and fines for its actual controller, Wang Yonghui, and other executives, while the company's stock has been marked with risk warnings due to false financial reporting [2][6]. Summary by Sections Company Penalties and Stock Status - On March 23, Xiangxue Pharmaceutical announced that Wang Yonghui received a warning and a fine of 10 million yuan, with several others also penalized. The company's stock will be marked with risk warnings, changing its name to "ST Xiangxue" while retaining the stock code "300147" [2]. - The stock will be suspended for one day starting March 24, 2025, and will resume trading on March 25, 2025 [2]. Violations and Financial Misreporting - The company was found to have false records in its 2019 annual report, which inflated profits by 53.83 million yuan, accounting for 45.98% of the total reported profit for that year [3]. - From 2016 to 2020, Xiangxue Pharmaceutical failed to disclose significant non-operating fund occupations involving related parties, with amounts of 585 million yuan, 845 million yuan, 1.408 billion yuan, 657 million yuan, and 1.357 billion yuan respectively [4]. Related Party Transactions - The company engaged in transactions that resulted in non-operating fund occupations, with undisclosed amounts in annual reports from 2016 to 2019, only revealing 1.262 billion yuan in the 2020 report [4][5]. - The undisclosed fund occupations represented significant percentages of the company's net assets, ranging from 2.22% to 38.79% across the years [4][5]. Management Accountability - Wang Yonghui was identified as the organizer of the fund occupation activities, leading to penalties for him and other executives, with fines ranging from 150,000 to 2 million yuan [6].

香港交易及結算所有限公司及香港聯合交易所有限公司對本公佈之內容概不負責，對其準確 性或完整性亦不發表任何聲明，且表明不會就因本公佈全部或任何部份內容或因倚賴該等內 容而引致之任何損失承擔任何責任。 INTERNATIONAL BUSINESS SETTLEMENT HOLDINGS LIMITED 國際商業結算控股有限公 司 （於百慕達註冊成立之有限公司） （股份代號：00147） 須予披露交易－有關 收購目標公司100%股權 買賣協議 董事會欣然宣佈，於二零二五年二月二十四日（交易時段後），賣方與買方訂立買賣協議，據 此，買方同意購買而賣方同意出售總代價為人民幣5百萬元之銷售股權。 上市規則之涵義 由於有關收購事項之最高適用百分比率（定義見上市規則）超過5%但低於25%，根據上市規 則第十四章，收購事項構成本公司的一項須予披露交易。因此，收購事項須遵守上市規則項 下的通告及公佈規定。 1 買賣協議 董事會欣然宣佈，於二零二五年二月二十四日（交易時段後），賣方與買方訂立買賣協議，據 此，買方同意購買而賣方同意出售總代價為人民幣5百萬元之銷售股權。 買賣協議之主要條款載列如下： 日期： 二零二五年二月二十四日 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公佈之內容概不負責，對其 準確性或完整性亦不發表任何聲明，且表明不會就因本公佈全部或任何部份內容或因倚 賴該等內容而引致之任何損失承擔任何責任。 更改香港股份過戶登記分處 國際商業結算控股有限公司 (「本公司」) 董事會宣佈自二零二五年二月十七日起, 本公 司之香港股份過戶登記分處將更改為: - 卓佳證券登記有限公司 香港夏慤道 16 號 遠東金融中心 17 樓 電話 : (852) 2980 1333 傳真 : (852) 2810 8185 由二零二五年二月十七日起, 有關本公司之股份過戶及登記手續將由卓佳證券登記有限 公司辦理。 於二零二五年二月十四日下午四時三十分後仍未領取之股票, 可於二零二五 年二月十七日起從卓佳證券登記有限公司領取。 承董事會命 INTERNATIONAL BUSINESS SETTLEMENT HOLDINGS LIMITED 國 際 商 業 結 算 控 股 有 限 公 司 （於百慕達註冊成立之有限公司） （股份代號：00147） 於本公佈日期，董事會由執行董事袁亮先生及陳少達先生；非執行董事劉雨先生；及獨 立非執行董事葉勇先 ...

INTERNATIONAL BUSINESS SETTLEMENT HOLDINGS LIMITED 國際商業結算控股有限公 司 (Incorporated in Bermuda with limited liability) （於百慕達註冊成立之有限公司） International Business Settlement Holdings Limited (the "Company") Notification of publication of Interim Report 2024 (the "Current Corporate Communication") The English and Chinese versions of the Company's Current Corporate Communications (Note) are available on the Company's website at www.147hk.com and the website of The Stock Exchange of Hong Kong Limited (the "Stock Exchang ...